SE0301320D0 - Positive modulators of nicotinic acetylcholine receptors - Google Patents
Positive modulators of nicotinic acetylcholine receptorsInfo
- Publication number
- SE0301320D0 SE0301320D0 SE0301320A SE0301320A SE0301320D0 SE 0301320 D0 SE0301320 D0 SE 0301320D0 SE 0301320 A SE0301320 A SE 0301320A SE 0301320 A SE0301320 A SE 0301320A SE 0301320 D0 SE0301320 D0 SE 0301320D0
- Authority
- SE
- Sweden
- Prior art keywords
- nicotinic acetylcholine
- acetylcholine receptors
- positive modulators
- sup
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301320A SE0301320D0 (sv) | 2003-05-06 | 2003-05-06 | Positive modulators of nicotinic acetylcholine receptors |
CNA2004800123148A CN1784230A (zh) | 2003-05-06 | 2004-05-04 | 烟碱性乙酰胆碱受体的正向调节剂 |
US10/553,915 US20070179172A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
AU2004237130A AU2004237130A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
EP04731052A EP1631288A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
PCT/GB2004/001934 WO2004098600A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
CA002524019A CA2524019A1 (en) | 2003-05-06 | 2004-05-04 | Positive modulators of nicotinic acetylcholine receptors |
KR1020057021042A KR20060009899A (ko) | 2003-05-06 | 2004-05-04 | 니코틴성 아세틸콜린 수용체의 양성 조절제 |
BRPI0410050-6A BRPI0410050A (pt) | 2003-05-06 | 2004-05-04 | método de tratamento ou de profilaxia de distúrbios psicóticos, distúrbios de prejuìzo intelectual ou doenças ou condições nos quais a modulação do receptor alfa7-nicotìnico é benéfica, composição farmacêutica, método de tratamento ou de profilaxia de doenças, uso de um composto, composto, e, método de preparação de um composto |
MXPA05011785A MXPA05011785A (es) | 2003-05-06 | 2004-05-04 | Moduladores positivos de receptores de acetilcolina nicotinicos. |
JP2006506220A JP2006525302A (ja) | 2003-05-06 | 2004-05-04 | ニコチン性アセチルコリン受容体の正のモジュレーター |
ZA200508860A ZA200508860B (en) | 2003-05-06 | 2005-11-01 | Positive modulators of nicotinic acetylcholine receptors |
NO20055766A NO20055766L (no) | 2003-05-06 | 2005-12-05 | Positive modulatorer av nikotinacetylcholinreseptorer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301320A SE0301320D0 (sv) | 2003-05-06 | 2003-05-06 | Positive modulators of nicotinic acetylcholine receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0301320D0 true SE0301320D0 (sv) | 2003-05-06 |
Family
ID=20291221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0301320A SE0301320D0 (sv) | 2003-05-06 | 2003-05-06 | Positive modulators of nicotinic acetylcholine receptors |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070179172A1 (sv) |
EP (1) | EP1631288A1 (sv) |
JP (1) | JP2006525302A (sv) |
KR (1) | KR20060009899A (sv) |
CN (1) | CN1784230A (sv) |
AU (1) | AU2004237130A1 (sv) |
BR (1) | BRPI0410050A (sv) |
CA (1) | CA2524019A1 (sv) |
MX (1) | MXPA05011785A (sv) |
NO (1) | NO20055766L (sv) |
SE (1) | SE0301320D0 (sv) |
WO (1) | WO2004098600A1 (sv) |
ZA (1) | ZA200508860B (sv) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
FR2884822B1 (fr) * | 2005-04-22 | 2007-06-29 | Aventis Pharma Sa | Derives de triazines, leur preparation et leur application en therapeutique |
DE102005027169A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Tetrahydrochinolinderivate |
WO2008109007A1 (en) * | 2007-03-02 | 2008-09-12 | Cara Therapeutics, Inc. | Bridged phenanthridines |
CN103977003A (zh) | 2007-04-02 | 2014-08-13 | 帕金森氏病研究院 | 用于降低治疗的副作用的方法和组合物 |
US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
EP2647628A1 (en) * | 2012-04-02 | 2013-10-09 | Almirall, S.A. | Substituted tricyclic compounds with activity towards ep1 receptors |
WO2014017803A1 (ko) * | 2012-07-23 | 2014-01-30 | 주식회사 유한양행 | 퓨란-함유 융합 고리 화합물 또는 그의 염 및 이를 포함하는 약학 조성물 |
EP3180086A4 (en) * | 2014-07-23 | 2017-12-27 | Northeastern University | Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological and inflammatory conditions |
WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
CN107991409B (zh) * | 2017-11-28 | 2020-04-24 | 中国医学科学院肿瘤医院 | 采用高效合相色谱同时测定血浆中12种磺胺类药物的方法 |
CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3631050A (en) * | 1968-11-13 | 1971-12-28 | Parke Davis & Co | Hexahydro-9b-methylfuro(3 2-c) quinoline compounds |
JPS63225358A (ja) * | 1986-10-31 | 1988-09-20 | Sumitomo Pharmaceut Co Ltd | シクロペンタ〔b〕キノリン誘導体 |
CA2273882A1 (en) * | 1996-12-18 | 1998-06-25 | Eli Lilly And Company | Combinatorial process for preparing tetrahydroquinoline libraries |
US5925527A (en) * | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
DE10137488A1 (de) * | 2001-08-03 | 2003-02-20 | Gruenenthal Gmbh | Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate |
-
2003
- 2003-05-06 SE SE0301320A patent/SE0301320D0/sv unknown
-
2004
- 2004-05-04 EP EP04731052A patent/EP1631288A1/en not_active Ceased
- 2004-05-04 BR BRPI0410050-6A patent/BRPI0410050A/pt not_active IP Right Cessation
- 2004-05-04 JP JP2006506220A patent/JP2006525302A/ja active Pending
- 2004-05-04 CN CNA2004800123148A patent/CN1784230A/zh active Pending
- 2004-05-04 KR KR1020057021042A patent/KR20060009899A/ko not_active Application Discontinuation
- 2004-05-04 CA CA002524019A patent/CA2524019A1/en not_active Abandoned
- 2004-05-04 AU AU2004237130A patent/AU2004237130A1/en not_active Abandoned
- 2004-05-04 MX MXPA05011785A patent/MXPA05011785A/es not_active Application Discontinuation
- 2004-05-04 US US10/553,915 patent/US20070179172A1/en not_active Abandoned
- 2004-05-04 WO PCT/GB2004/001934 patent/WO2004098600A1/en active Application Filing
-
2005
- 2005-11-01 ZA ZA200508860A patent/ZA200508860B/en unknown
- 2005-12-05 NO NO20055766A patent/NO20055766L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060009899A (ko) | 2006-02-01 |
BRPI0410050A (pt) | 2006-04-25 |
EP1631288A1 (en) | 2006-03-08 |
CN1784230A (zh) | 2006-06-07 |
JP2006525302A (ja) | 2006-11-09 |
ZA200508860B (en) | 2007-03-28 |
US20070179172A1 (en) | 2007-08-02 |
NO20055766L (no) | 2005-12-05 |
AU2004237130A1 (en) | 2004-11-18 |
WO2004098600A1 (en) | 2004-11-18 |
MXPA05011785A (es) | 2006-01-26 |
CA2524019A1 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1079519A1 (en) | Furyl compounds | |
SE9903998D0 (sv) | New compounds | |
HK1080470A1 (en) | Heterocyclic compounds | |
SE0401971D0 (sv) | Piperidne derivatives | |
HK1079522A1 (en) | Thienyl compounds | |
IL176110A0 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
HK1095139A1 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0302139D0 (sv) | Novel compounds | |
SE0401970D0 (sv) | Novel compounds | |
SE9903997D0 (sv) | New compounds | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
TW200626581A (en) | Compounds, compositions containing them, preparation thereof and uses thereof | |
SE0302756D0 (sv) | Novel Compounds | |
SE0303280D0 (sv) | Novel compounds | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
AU2003253558A1 (en) | Naphthamide derivatives and their use | |
SE0102058D0 (sv) | New Salts II | |
NO20055998L (no) | Diarylmetylidenpiperidinderivater, preparater derav og anvendelse derav | |
SE0400285D0 (sv) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
NO20063618L (no) | Diarylmetylpiperidinderivater, fremstilling og anvendelse derav | |
NO20063617L (no) | Diarylmetylidenpiperidinderivater, fremstilling og anvendelse derav | |
SE0303075D0 (sv) | 4-substituted imidazoles | |
TW200616970A (en) | Compounds, compositions containing them, preparation thereof and uses thereof |